Details for 2021207859

Up to date per 03.04.2026

Actions

Title / Product Name

PEGYLIERTE LIPOSOMEN ZUR AUSLIEFERUNG VON IMMUNOGEN-KODIERENDER RNS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021207859

EP Publication Number

3970742

E-Number

1493998

Language

PCT Number

Publication Date

23.03.2022 A

25.05.2022 B1

Registration Date

25.05.2022

AT Publication Date

15.06.2022

Application Date

31.08.2011

Registration Number

Priorities

31.08.2010

37882610 P

IPC

A61K 39/39 20060101AFI20220204BHEP

Maximum Duration of Protection

31.08.2031

Owner

GlaxoSmithKline Biologicals S.A.Rue de l'Institut, 89 1330 RixensartBE

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

GEALL, Andrew Emeryville, 94662-8097US

VERMA, Ayush Emeryville, 94662-8097US

Information about Fees